CLINICAL AND IMMUNOLOGICAL RESPONSE TO TYPHOID VACCINATION WITH PARENTERAL OR ORAL VACCINES IN 2 GROUPS OF 30 RECRUITS

被引:28
作者
NISINI, R
BISELLI, R
MATRICARDI, PM
FATTOROSSI, A
DAMELIO, R
机构
[1] DASRS, Rep. Medicina, Aeroporto Pratica di Mare, 00040 Pomezia, Roma
关键词
TYPHOID FEVER; CLINICAL RESPONSE; IMMUNOLOGICAL RESPONSE;
D O I
10.1016/0264-410X(93)90237-R
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The clinical and immunological responses to typhoid vaccination with parenteral and oral vaccines in two groups of 30 adult male subjects were studied. Specific-anti-Salmonella typhi cell-mediated immunity and total or specific anti-lipopolysaccharide faecal immunoglobulin (Ig) A titres in vaccinated subjects were monitored. Cellular antibacterial activity was significantly increased only in orally vaccinated subjects. Serum arming activity and inhibition experiments suggested an IgA-dependent cellular cytotoxicity in those orally vaccinated. In these subjects, a total and anti-lipopolysaccharide faecal IgA increase was observed lasting up to 8 months after completion of the vaccination schedule. In parenteral vaccinated subjects, an early onset transitory increase of IgM rheumatoid factor was observed. Oral vaccine was well tolerated and free of side effects, whereas 65% of parenterally vaccinated subjects reported side effects such as fever, headache, malaise and local tenderness in the injection site.
引用
收藏
页码:582 / 586
页数:5
相关论文
共 20 条
[1]   DEMONSTRATION OF SPECIFIC IGA IN HUMAN FECES AFTER IMMUNIZATION WITH LIVE TY21A SALMONELLA-TYPHI VACCINE [J].
CANCELLIERI, V ;
FARA, GM .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (03) :482-484
[2]  
DAHAM SK, 1982, CLIN EXP, V48, P389
[3]   CELLULAR AND HUMORAL MODIFICATIONS DURING RESPONSE TO HBSAG VACCINE IN HEALTHY-SUBJECTS [J].
DAMELIO, R ;
LEMOLI, S ;
FATTOROSSI, A ;
NISINI, R ;
MATRICARDI, PM ;
PAGANELLI, R ;
CABELLO, A ;
CHERCHI, M ;
SEMINARA, R ;
SIRIANNI, MC ;
SODDU, S ;
CASTAGLIUOLO, PP ;
AIUTI, F .
ANNALES DE L INSTITUT PASTEUR-VIROLOGY, 1985, 136E (04) :327-340
[4]  
EISENSTEIN TK, 1984, J IMMUNOL, V133, P958
[5]   ISOLATION AND CHARACTERIZATION OF GAL-E MUTANT TY 21A OF SALMONELLA-TYPHI - CANDIDATE STRAIN FOR A LIVE, ORAL TYPHOID VACCINE [J].
GERMANIER, R ;
FURER, E .
JOURNAL OF INFECTIOUS DISEASES, 1975, 131 (05) :553-558
[6]   SAFETY, INFECTIVITY, IMMUNOGENICITY, AND INVIVO STABILITY OF 2 ATTENUATED AUXOTROPHIC MUTANT STRAINS OF SALMONELLA-TYPHI, 541TY AND 543TY, AS LIVE ORAL VACCINES IN HUMANS [J].
LEVINE, MM ;
HERRINGTON, D ;
MURPHY, JR ;
MORRIS, JG ;
LOSONSKY, G ;
TALL, B ;
LINDBERG, AA ;
SVENSON, S ;
BAQAR, S ;
EDWARDS, MF ;
STOCKER, B .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (03) :888-902
[7]  
LEVINE MM, 1987, LANCET, V2, P10459
[8]  
LISSNER CR, 1983, J IMMUNOL, V131, P3006
[9]  
NATH TR, 1977, CLIN EXP IMMUNOL, V30, P38